Michele Valmasoni.pdf

Research interest and career highlight

Prof. Michele Valmasoni is the clinical and research coordinator of the Esophageal Cancer Program at University of Padova Center for Esophageal Diseases.

In 2017 he spent some period as visiting clinical observer at Memorial Sloan Kettering Cancer Center focusing on minimally invasive treatments of esophageal cancer. Following this experience, he introduced total minimally invasive esophagectomy at University Hospital of Padova.

He ideated a research project for the development of tissue engineered esophageal graft from human cadaveric donors that is currently funded and ongoing. He collaborates with an international research group in defining and maintaining guidelines for the reporting of clinical studies in scientific journals.

He is Fellow of the American College of Surgeon and founding member and vice president of SISME, the Italian Society for the Study of Esophageal Diseases.

Research interests

Upper GI surgical oncology
Translational research in upper GI oncology
Cancer cachexia
Esophageal tissue engineering
Application of digital technologies to surgery
Benign esophageal diseases

1: De Pascale S, Parise P, Valmasoni M, Weindelmayer J, Terraneo F, Cella CA, Giacopuzzi S, Cossu A, Massaron S, Elmore U, Merigliano S, Fumagalli Romario U, On Behalf Of The Italian  Society For The Study Of Esophageal Diseases Sisme. Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis. Cancers (Basel). 2021 Feb 7;13(4):666.

2: Ruzzo A, Graziano F, Bagaloni I, Di Bartolomeo M, Prisciandaro M, Aprile G, Ongaro E, Vincenzi B, Perrone G, Santini D, Fornaro L, Vivaldi C, Tomasello G, Loupakis F, Lonardi S, Fassan M, Valmasoni M, Sarti D, Lorenzini P, Catalano V, Bisonni R, Del Prete M, Collina G, Magnani M. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab. Gastric Cancer. 2020 Nov;23(6):1064-1074.

3: Valmasoni M, Capovilla G, Pierobon ES, Moletta L, Provenzano L, Costantini M, Salvador R, Merigliano S. A Technical Modification to the Circular Stapling Anastomosis Technique During Minimally Invasive Ivor Lewis Procedure. J Laparoendosc Adv Surg Tech A. 2019 Dec;29(12):1585-1591.

4: Provenzano L, Salvador R, Cutrone C, Capovilla G, Moletta L, Nicoletti L, Costantini M, Merigliano S, Valmasoni M. Traction on the septum during transoral septotomy for Zenker diverticulum improves the final outcome. Laryngoscope. 2020 Mar;130(3):637-640.

5: Valmasoni M, Pierobon ES, Zanchettin G, Briscolini D, Moletta L, Ruol A, Salvador R, Merigliano S. Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery. Ann Surg Oncol. 2018 Sep;25(9):2747-2755.

6: Valmasoni M, Pierobon ES, De Pasqual CA, Zanchettin G, Moletta L, Salvador R, Costantini M, Ruol A, Merigliano S. Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study. Ann Surg Oncol. 2017 Mar;24(3):763-769.

7: Valmasoni M, Pierobon ES, Ruol A, De Pasqual CA, Zanchettin G, Moletta L, Salvador R, Costantini M, Merigliano S. Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients. PLoS One. 2016 Apr 18;11(4):e0153068.

8: Valmasoni M, Pierobon ES, Capovilla G, Piangerelli A, Moletta L, Costantini M, Salvador R, Merigliano S. Providing surgery for cancer during the COVID-19 pandemic: experience of a northern Italian referral centre. Br J Surg. 2020 Aug;107(9):e326-e327.

9: Moletta L, Pierobon ES, Capovilla G, Costantini M, Salvador R, Merigliano S, Valmasoni M. International guidelines and recommendations for surgery during Covid-19 pandemic: A Systematic Review. Int J Surg. 2020 Jul;79:180-188.